PURIFIED PROTEINS

IPC classification:

A61K 38/20, B01D 15/36, C07K 14/545

Agent:

Multiple attorneys, Mathys & Squire LLP

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

Genz 112638 for treating Gaucher or Fabry disease in combination therapy

IPC classification:

A61K 31/4025, A61P 35/00, C07D 405/06

Applicant:

Genzyme Corporation

Agent:

Potter Clarkson LLP

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ NO OPPOSITION FILED WITHIN TIMELIMIT

COMPOSITIONS AND METHODS FOR TRANSMUCOSAL ABSORPTION

IPC classification:

A61K 9/00, A61K 31/135

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ GRANT OF PATENT INTENDED

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:

A61K 31/439, A61P 25/00, A61P 35/00, C07D 453/02, C07D 471/08

Applicant:

Genzyme Corporation

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ GRANT OF PATENT INTENDED

BIOGLASS WITH GLYCOSAMINOGLYCANS

IPC classification:

A61F 13/00, A61K 9/14, A61K 33/04

Agent:

Multiple attorneys, Mathys & Squire LLP

Status:

█ GRANT OF PATENT INTENDED

COMPOSITIONS AND METHODS FOR TREATING PROTEINOPATHIES

IPC classification:

A61K 38/46, A61P 25/28

Applicant:

Genzyme Corporation

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION IN PROGRESS

IL-6 ANTAGONISTS AND USES THEREOF

IPC classification:

A61P 27/02, C07K 16/24

Agent:

Vossius & Partner Patentanwälte Rechtsanwälte mbB

Agent:

Multiple attorneys, Mathys & Squire LLP

Status:

█ EXAMINATION IN PROGRESS

BIOACTIVE GLASS WITH ETHYLENE OXIDE PROPYLENE OXIDE BLOCK COPOLYMERS

IPC classification:

A61F 2/28

Agent:

Multiple attorneys, Mathys & Squire LLP

Status:

█ GRANT OF PATENT INTENDED

METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:

C07D 277/30, C07D 417/06, C07D 453/02

Applicant:

Genzyme Corporation

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION IN PROGRESS

CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY

IPC classification:

A61K 9/00, A61K 38/20, A61K 47/10, A61K 47/26

Agent:

Multiple attorneys, Mathys & Squire LLP

Status:

█ EXAMINATION REQUESTED

SODIUM CONTAINING SOL-GEL DERIVED BIOACTIVE GLASSES AND USES THEREOF INCLUDING HEMOSTASIS

IPC classification:

C03C 3/078, C08K 9/06

Agent:

Multiple attorneys, Mathys & Squire LLP

Status:

█ EXAMINATION REQUESTED

COMPOSITIONS AND METHODS FOR MANUFACTURING SOL-GEL DERIVED BIOACTIVE BOROPHOSPHATE GLASSES FOR MEDICAL APPLICATONS

IPC classification:

C03C 3/078, C08K 9/06

Agent:

Multiple attorneys, Mathys & Squire LLP

Status:

█ EXAMINATION REQUESTED

PIPERAZINE DERIVATIVES AND THEIR USE AS KIT MODULATORS

IPC classification:

A61K 31/517, A61K 31/5377, A61P 17/00, C07D 239/94, C07D 401/12, C07D 403/04, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 487/04

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION IN PROGRESS

SALT FORMS OF (S)-QUINUCLIDIN-3-YL (2-(2-(4-FLUOROPHENYL)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE

IPC classification:

A61K 31/439, A61P 3/00, A61P 35/00, C07D 453/00

Applicant:

Genzyme Corporation

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION IN PROGRESS

ALBUMIN VARIANTS BINDING TO FCRN

IPC classification:

G01N 33/50

Agent:

Stephen Garner, Mathys & Squire LLP

Agent:

Rachel Clare Williams, Novozymes Biopharma UK Limited

Status:

█ EXAMINATION IN PROGRESS

PYRIDAZINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

IPC classification:

A61K 31/50

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION REQUESTED

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

IPC classification:

A61K 31/53, A61P 35/00, C07D 487/04

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ GRANT OF PATENT INTENDED

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

IPC classification:

A61K 31/498, A61P 35/00, C07D 235/30, C07D 401/04, C07D 401/12, C07D 403/12, C07D 403/14, C07D 405/12, C07D 409/12

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION REQUESTED

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:

A61K 31/439, A61P 9/00

Applicant:

Genzyme Corporation

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION IN PROGRESS

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

IPC classification:

C07K 16/28, C07K 16/32, C07K 16/40, A61K 47/60

Applicant:

Genzyme Corporation

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION REQUESTED

ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT

IPC classification:

A61K 31/4025, A61K 45/06, A61P 35/00, C07D 405/06

Applicant:

Genzyme Corporation

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION IN PROGRESS

NAMPT INHIBITORS AND METHODS

IPC classification:

A61K 31/438, A61K 31/444, A61K 31/537, A61P 31/12, A61P 35/00, A61P 37/06, C07D 491/107, C07D 491/20, C07D 498/10

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ EXAMINATION REQUESTED

EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE

IPC classification:

A61K 31/047, A61K 31/135, A61P 21/02

Agent:

Stephen Garner, Mathys & Squire LLP

Status:

█ Request for examination was made